Bank of America
CTOR

Bank of America’s Citius Oncology CTOR Stock Holding History

Bank of America’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.49M Hold
3,835,160
– – ﹤0.01% 4059
2026
Q1 		$2.37M Buy
3,835,160
+3,834,946
+1,792,031% +$3.85M ﹤0.01% 3999
2025
Q4 		$214 Sell
214
-50
-19% -$72 ﹤0.01% 6683
2025
Q3 		$536 Sell
264
-8,307
-97% -$18K ﹤0.01% 7576
2025
Q2 		$37.3K Buy
8,571
+8,411
+5,257% +$9.82K ﹤0.01% 6895
2025
Q1 		$149 Hold
160
– – ﹤0.01% 7757
2024
Q4 		$184 Hold
160
– – ﹤0.01% 7609
2024
Q3 		$222 Buy
+160
New +$1.14K ﹤0.01% 7544

Other funds holding CTOR

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Bank of America's CTOR Position: Q2 2026 in Review

Bank of America held its Citius Oncology (CTOR) position steady in Q2 2026 at 3,835,160 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #4059.

Bank of America first reported a position in CTOR in Q3 2024 and has held it in 8 quarters since. 19 funds tracked by Wall St. Rank hold CTOR as of Q2 2026.

  • Bank of America held 3,835,160 shares of Citius Oncology worth $2.49M as of Q2 2026.
  • Bank of America left its Citius Oncology share count unchanged in Q2 2026.
  • Citius Oncology made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4059 holding.
  • Bank of America first reported a position in Citius Oncology in Q3 2024 and has held it in 8 quarters since.
  • 19 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.